Uptravi 1,600 MCG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FX1KZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,298
Award facts
- Contract value 100% obligated
- $36,297.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,297.66 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,600 MCG tablets of UPTRAVI (a pulmonary hypertension treatment) in a 60-count package. The delivery order, which carries no set-aside designation, was awarded on November 5, 2025, with an ultimate completion date of November 28, 2025. DMS Pharmaceutical Group is the sole contractor on this award with no identified subcontractors.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition vehicle designed to streamline pharmaceutical supply to Department of Defense healthcare facilities worldwide. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue multiple firm fixed-price delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables. DMS Pharmaceutical Group's award reflects its competitive capability and established performance record in supplying specialized pharmaceutical products to federal military medical operations.
Quick answers
Who was awarded contract SPE2DB26FX1KZ?
SPE2DB26FX1KZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DB26FX1KZ worth?
The government has obligated $36,298 on SPE2DB26FX1KZ.
Is contract SPE2DB26FX1KZ an order under another contract?
Yes. SPE2DB26FX1KZ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1KZ competed?
The extent of competition for SPE2DB26FX1KZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award